Hua Medicine (Shanghai) Ltd. (HKG:2552)

Hua Medicine (Shanghai) Statistics

Total Valuation

HKG:2552 has a market cap or net worth of HKD 3.61 billion. The enterprise value is 2.73 billion.

Market Cap	3.61B
Enterprise Value	2.73B

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2552 has 988.01 million shares outstanding. The number of shares has increased by 2.33% in one year.

Current Share Class	988.01M
Shares Outstanding	988.01M
Shares Change (YoY)	+2.33%
Shares Change (QoQ)	+2.44%
Owned by Insiders (%)	5.55%
Owned by Institutions (%)	0.80%
Float	652.80M

Valuation Ratios

The trailing PE ratio is 2.98.

PE Ratio	2.98
Forward PE	n/a
PS Ratio	6.57
PB Ratio	3.22
P/TBV Ratio	3.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	2.21
EV / Sales	4.97
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.17, with a Debt / Equity ratio of 0.30.

Current Ratio	6.17
Quick Ratio	5.57
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17.79

Financial Efficiency

Return on equity (ROE) is 254.05% and return on invested capital (ROIC) is -12.30%.

Return on Equity (ROE)	254.05%
Return on Assets (ROA)	-6.04%
Return on Invested Capital (ROIC)	-12.30%
Return on Capital Employed (ROCE)	-11.50%
Weighted Average Cost of Capital (WACC)	9.67%
Revenue Per Employee	1.92M
Profits Per Employee	4.32M
Employee Count	285
Asset Turnover	0.33
Inventory Turnover	1.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.84% in the last 52 weeks. The beta is 1.11, so HKG:2552's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	+44.84%
50-Day Moving Average	3.13
200-Day Moving Average	3.42
Relative Strength Index (RSI)	65.90
Average Volume (20 Days)	4,255,675

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2552 had revenue of HKD 548.54 million and earned 1.23 billion in profits. Earnings per share was 1.22.

Revenue	548.54M
Gross Profit	311.98M
Operating Income	-161.23M
Pretax Income	1.23B
Net Income	1.23B
EBITDA	-145.29M
EBIT	-161.23M
Earnings Per Share (EPS)	1.22

Balance Sheet

The company has 1.22 billion in cash and 335.70 million in debt, with a net cash position of 879.80 million or 0.89 per share.

Cash & Cash Equivalents	1.22B
Total Debt	335.70M
Net Cash	879.80M
Net Cash Per Share	0.89
Equity (Book Value)	1.12B
Book Value Per Share	1.13
Working Capital	1.21B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	16.30M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 56.87%, with operating and profit margins of -29.39% and 224.44%.

Gross Margin	56.87%
Operating Margin	-29.39%
Pretax Margin	224.44%
Profit Margin	224.44%
EBITDA Margin	-26.49%
EBIT Margin	-29.39%
FCF Margin	n/a

Dividends & Yields

HKG:2552 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.33%
Shareholder Yield	-2.33%
Earnings Yield	34.14%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3